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Background: Doppler ultrasound is a key tool in evaluating carotid stenosis severity.
Peak systolic and end-diastolic velocity (PSV; EDV) are widely correlated with the
angiographic cross-sectional stenosis severity (CSSS). With intravascular ultrasound
(IVUS) validation, PSV and EDV thresholds for CS >50%/>75% lumen diameter/
area stenosis were established, conﬁrming that CSSS is a signiﬁcant determinant of
PSV and EDV. Here, we tested the hypothesis that carotid longitudinal lesion length
(LL) may also affect PSV and EDV.
Methods: 300 consecutive patients (age 47-83, 64.3% men) with CS>50% (63.3%
symptomatic), were evaluated in CARUS (Carotid Artery intravasculaR Ultrasound
academic Study). EPD use for IVUS imaging (62.8%) was left to operator (ﬁlters z
3/4, proximal z
1/4). In 7 (2.4%) patients IVUS was not performed as angiographic
CSSS was considered too tight.
Results: Carotid LL of 7mm (Fig; ICA¼Internal Carotid Artery) provided the best
cutoff for LL effect on PSV and EDV. By regression analysis, the impact of LL on
Doppler velocities was best represented by equations: PSV¼0.31*LL/MLA + 2.02
and EDV¼0.12*LL/MLA + 0.63 [m/s] (r¼0.61 and r¼0.54, p<0.001 for both) where
MLA is minimal lumen area by IVUS [mm2]. MLA outperformed angiographic
parameters of CSSS in its impact on PSV and EDV.
Conclusions: This study provides, for the ﬁrst time, systematic evidence that
carotid longitudinal lesion length affects PSV and EDV. In addition, we determined
the lesion length cutoff value for an effect on PSV/EDV, and equations that
incorporate both lesion length and cross-sectional stenosis severity in Doppler
velocities.B24 JACC Vol 62/18/Suppl B j OcTCT-75
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Background: Current risk-stratiﬁcation tools in internal carotid artery atheromatous
stenosis (CS) are largely ineffective. CS degree is a poor marker of symptom risk
while plaque morphology may play a signiﬁcant role. Although intravascular ultra-
sound (IVUS) offers high-resolution (axial 0.12mm for 20MHz transducer) visu-
alization, the reproducibility of conventional (ie, phenotypic ‘plaque type’) virtual
histology (VH-IVUS) carotid plaque classiﬁcation is only moderate, limiting evalu-
ation of wider applicability of this modality.
Methods: We developed and implemented a novel software-based algorithm for
detailed fully-quantitative VH-IVUS (qVH-IVUS) analysis of key CS plaque
components known for their role in plaque rupture/thrombosis. In 21 plaques we
validated inter-transducer (n¼2) and inter-observer (n¼3) reproducibility of qVH-
IVUS analysis including (not limited to) minimal ﬁbrous cap thickness, and peak
conﬂuent necrotic core area, thickness and arc. Next we employed the qVH-IVUS
algorithm to evaluate CS lesions in 252 consecutive patients (age 47–83, 63.4% men,
h/o CS-attributable symptoms in 50.3%) presenting for potential CS revascularization.
Matched ChromaFlo images were routinely used for improved luminal border
delineation. Use of EPD for CS imaging (64%) was left to operator (ﬁlters z 3/4,
proximal z 1/4).
Results: No IVUS imaging-related complications occurred by cerebral angio-
gram or neurological consultation/imaging. Values in Table are meanSEM or
n(%).A
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MLA (mm2) 6.20.3 6.90.5 6.30.3 6.50.5 6.60.2 6.40.3 0.292
min FC
thickn (mm)
0.410.04 0.340.05 0.160.02 0.190.03 0.370.03 0.170.01 <0.001
conﬂ NC
area (mm2)
2.50.3 3.00.2 4.40.4 3.40.5 2.80.2 4.10.3 <0.001
conﬂ NC arc
( )
67.26 87.16 121.69 94.09 80.85 114.97 <0.001
conﬂ NC
thickn (mm)
0.880.04 1.070.07 1.340.06 1.160.11 0.980.04 1.300.05 <0.001
conﬂ Ca
area (mm2)
1.00.1 1.00.2 1.40.2 2.20.3 1.00.1 1.60.1 0.003
conﬂ Ca arc
( )
54.85.8 59.84.3 78.87.2 102.313 58.15.7 84.56.3 0.011
PIT, n (%) 15 (17.9) 6 (14.6) 6 (6.5) 2 (5.9) 21 (16.8) 8 (6.3) 0.021
FCa, n (%) 4 (4.8) 1 (2.4) 0 (0) 2 (5.9) 5 (4.0) 2 (1.6) 0.721
FA, n (%) 35 (41.7) 14 (34.1) 17 (18.3) 6 (17.6) 49 (39.2) 23 (18.1) <0.001
CaFA, n (%) 14 (16.7) 4 (9.8) 1 (1.1) 4 (11.8) 18 (14.4) 5 (3.9) 0.023
PCaN, n (%) 1 (1.2) 2 (4.9) 9 (9.7) 3 (8.8) 3 (2.4) 12 (9.4) 0.037
CaTCFA, n
(%)
3 (3.6) 3 (7.3) 11 (11.8) 10 (29.4) 6 (4.8) 21 (16.5) 0.005
TCFA, n (%) 12 (14.3) 11 (26.8) 49 (52.7) 7 (20.6) 23 (18.4) 56 (44.1) <0.001
TCFA +
CaTCFA +
PCaN, n (%)
16 (19.0) 16 (39.0) 69 (74.2) 20 (58.8) 32 (25.6) 89 (70.1) <0.001Conclusions: Novel fully-quantitative qVH-IVUS crucial carotid plaque parameter
analysis reveals, on cross-sectional evaluation, signiﬁcant inter-group differences by
absence/presence/timing of neurological symptoms. As qVH-IVUS is reproducible, it
may importantly supplement conventional phenotypic VH plaque classiﬁcation and
thus play a role in multi-center/longitudinal studies on VH applicability to decision-
making in asymptomatic CS.tober 27–November 1, 2013 j TCT Abstracts/ORAL/Invasive Imaging
